Toggle light / dark theme

Salk Institute scientists have harnessed stem cell technology to generate the first human insulin-producing pancreatic cell clusters that can evade the immune system. Generated from induced pluripotent stem cells (iPSCs), these “immune shielded” human islet-like organoids (HILOs) controlled blood glucose following transplantation into a mouse model of diabetes, without the use of immunosuppressive drugs. The researchers suggest the achievement represents a major advance in the quest for a safe and effective treatment for type 1 diabetes (T1D), which impacts an estimated 1.6 million people in the United States, at a cost of $14.4 billion annually.

“Most type 1 diabetics are children and teenagers,” said Salk professor Ronald Evans, PhD, holder of the March of Dimes chair in molecular and developmental biology. Evans is senior author of the team’s paper, which is published in Nature. “This is a disease that is historically hard to manage with drugs. We hope that regenerative medicine in combination with immune shielding can make a real difference in the field by replacing damaged cells with lab-generated human islet-like cell clusters that produce normal amounts of insulin on demand.”

Evans and colleagues reported on their development in a paper titled, “Immune-evasive human islet-like organoids ameliorate diabetes.”

The coronavirus has wreaked havoc on our world’s economy, and many scientists and nations are scrambling to get a vaccine out. In today’s video, I will talk about what will happen when that vaccine actually appears:

Discord Link: https://discord.gg/brYJDEr
Patreon link: https://www.patreon.com/TheFuturistTom
Please follow our instagram at: https://www.instagram.com/the_futurist_tom
For business inquires, please contact [email protected]

The silk drive is still in the proof-of-concept stage and “unlikely in the foreseeable future to match the speed and storage capacity of state-of-the-art solid-state devices at a competitive cost,” according to Chinese and US researchers, who promised “substantial improvements in the speed and storage capacity of silk drives.”


Scientists at CAS and two separate US universities have jointly developed a storage medium made from silk proteins that can be implanted in the human body.

Anacardic acid, a compound found in cashew nuts, promoted myelin regeneration and eased neuronal damage and disability in two mouse models of multiple sclerosis (MS).

These protective effects were associated with maturation of myelin-producing cells and production of IL-33, an immune-related molecule with a neuroreparative role in the central nervous system (CNS, the brain and spinal cord).

Michigan State University researchers have created for the first time a miniature human heart model in the laboratory, complete with all primary heart cell types and a functioning structure of chambers and vascular tissue.

In the United States, is the No. 1 cause of death. “These minihearts constitute incredibly powerful models in which to study all kinds of cardiac disorders with a degree of precision unseen before,” said Aitor Aguirre, the study’s senior author and assistant professor of biomedical engineering at MSU’s Institute for Quantitative Health Science and Engineering.

This study, “Generation of Heart Organoids Modeling Early Human Cardiac Development Under Defined Conditions,” appears on the bioRxiv preprint server.

“Using microfluidics, computer modeling and other techniques, they found that about half of the cells age through a gradual decline in the stability of the nucleolus, a region of nuclear DNA where key components of protein-producing “factories” are synthesized,” a press release announcing the research explains. “In contrast, the other half age due to dysfunction of their mitochondria, the energy production units of cells.”


Researchers studying aging have discovered that cells tend to follow one of two aging pathways. The way each individual cell ages is determined early on, and scientists can predict how a cell will age based on early observations.